• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Innocan Pharma Corp (OP: INNPF )

    0.1464 UNCHANGED
    Last Price Updated: 9:38 AM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Innocan Pharma Corp

    Innocan Pharma Provides an Operational Update
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 21, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... 
    Via Newsfile
    Topics Intellectual Property
    Exposures Intellectual Property
    Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment
    A 4-year-old intact male border collie dog with a body weight of 22 kg was suffering from refractory idiopathic (drug-resistant)... 
    Via Newsfile
    Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Intellectual Property Supply Chain
    Exposures COVID-19 Intellectual Property Supply Chain
    Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 27, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Supply Chain
    Exposures COVID-19 Supply Chain
    Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Supply Chain
    Exposures COVID-19 Supply Chain
    Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF)... 
    Via Newsfile
    Topics Supply Chain
    Exposures COVID-19 Supply Chain
    Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Intellectual Property Supply Chain
    Exposures COVID-19 Intellectual Property Supply Chain
    Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... 
    Via Newsfile
    Topics Intellectual Property Supply Chain
    Exposures COVID-19 Intellectual Property Supply Chain
    Former Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Artificial Intelligence Supply Chain
    Exposures Artificial Intelligence COVID-19 Supply Chain
    Innocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Intellectual Property Supply Chain
    Exposures COVID-19 Intellectual Property Supply Chain
    Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement for Poland
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 1, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Economy Supply Chain
    Exposures COVID-19 Economy Supply Chain
    Innocan Pharma's CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of the Appearance of Wrinkles by up to 28.8% in 4 Weeks of Clinical Study
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Supply Chain
    Exposures COVID-19 Supply Chain
    Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness Solution
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 16, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Supply Chain
    Exposures COVID-19 Supply Chain
    Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturizer and Lubricant Treatment
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Intellectual Property Supply Chain
    Exposures COVID-19 Intellectual Property Supply Chain
    Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release of CBD into Bloodstream in Recent Animal Study
    Herzliya, Israel and Calgary Alberta--(Newsfile Corp. - June 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Intellectual Property Supply Chain
    Exposures COVID-19 Intellectual Property Supply Chain
    Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Supply Chain
    Exposures COVID-19 Supply Chain
    Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Intellectual Property Supply Chain
    Exposures COVID-19 Intellectual Property Supply Chain
    Innocan Pharma Engages Lytham Partners to Lead Investor Relations and Shareholder Communication Program
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 10, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... 
    Via Newsfile
    Topics Cannabis Supply Chain
    Exposures COVID-19 Cannabis Supply Chain
    Innocan Pharma Announces Trading on the OTCQB Venture Market and DTC Eligibility of Its Common Shares in the United States
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Supply Chain
    Exposures COVID-19 Supply Chain
    Innocan Pharma and Polyflame Announce an Exclusive Distribution Agreement in France
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 22, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB:... 
    Via Newsfile
    Topics Supply Chain
    Exposures COVID-19 Supply Chain
    Richard Serbin, Former Johnson & Johnson's VP and a Leading Global Strategy Advisor in the Healthcare Industry, to Join Innocan Pharma's Scientific Advisory Committee
    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)... 
    Via Newsfile
    Topics Intellectual Property Supply Chain
    Exposures COVID-19 Intellectual Property Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.